Hepatology - European Medical Journal

Continue

Hepatology

Abstracts
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
2 Mins
13th October 2020

Fibrosis-4 Score for Assessment of Liver Fibrosis is Useful in General Practice

Early recognition of liver fibrosis will be a challenge that continues in the coming years and should be performed by general practitioners (GP)…
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
2 Mins
13th October 2020

FIB-4 and APRI Scores Revalidation in a Cohort Study of 69,106 Chronic Hepatitis C Patients

Assessment of liver fibrosis is vital for enabling therapeutic decisions and prognostic evaluation of chronic hepatitis…
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
1 Mins
13th October 2020

Progress in Hepatitis C Testing as Part of the Hepatitis C Elimination Programme in Georgia

In April 2015, the country of Georgia, with a high prevalence of hepatitis C virus (HCV) infection (5.4% of the adult population, approximately 150,000 persons), embarked on the world’s first national HCV Elimination programme…
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
1 Mins
13th October 2020

Multivariant Surface Quasispecies in a Hepatitis B Virus Chronically Infected Individual with Concomitant and Continually Positive Surface Antigen and Anti-Hbs Biomarkers

Coexistence of hepatitis B virus (HBV) surface antigen (HBsAg) and antibodies (anti-HBs) can be found in 2.3–5.2% of chronic HBV (CHB) infected individuals…
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
2 Mins
13th October 2020

Contrast-Enhanced Ultrasound Algorithms for the Noninvasive Diagnosis of Hepatocellular Carcinoma in High-Risk Patients - A Prospective Multicentre Study (DEGUM CEUS HCC Trial)

Hepatocellular carcinoma (HCC) can be diagnosed noninvasively in high-risk patients by means of contrast-enhanced imaging…
2 Mins
28th May 2019

The Role of Adipose Tissue in Metabolic and Cardiovascular Complications After Liver Transplantation

Metabolic and cardiovascular complications are an important burden in patients after liver transplantation (LT) for many reasons, including as a result…
2 Mins
28th May 2019

Efficacy of Oral Thrombopoietin Receptor Agonist Lusutrombopag in Chronic Liver Disease by Underlying Disease Aetiology

Among patients with chronic liver disease (CLD), thrombocytopenia (TCP) is a frequent complication.1,2 Before invasive procedures and surgery in CLD…
3 Mins
28th May 2019

A Comparison of Currently Available Direct-Acting Antiviral Hepatitis C Virus Therapy in Canada: On the Path to Elimination

As many as 250,000 Canadians are living with hepatitis C virus (HCV) infection,1 and specific populations, such as people who use drugs (PWUD)…